Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Role of miRNAs in Cancer : Analysis of Their Targetome
| Role of miRNAs in Cancer : Analysis of Their Targetome |
| Autore | Navarro Alfons |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (302 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
adrenocortical carcinoma
angiogenesis biomarker Bladder cancer breast cancer Burkitt lymphoma cancer cancer diagnosis cancer treatment ccRCC cell growth chemotherapy circular RNAs drug resistance EBV EMT EP4 epithelial to mesenchymal transition (EMT) exosomes genetic marker glioblastoma HBV HCV HHV-8 HPV immune regulation interplay liquid biopsies liquid biopsy long non-coding RNAs (lncRNAs) lymphangiogenesis MCPyV metastasis MGMT micro RNA microRNA microRNA-361 microRNAs miR-378a-3p miR526b miR655 miRNA n/a non-coding RNA oncomiRNA pancreatic cancer personalized medicine PI3K/Akt post-transcriptional regulation prognosis prognostic biomarker progression radioactive iodine radioresistance radiotherapy SNAIL (SNAI1) transcription factor survival target temozolomide thyroid carcinoma transcription factor translational medicine tumor tumor microenvironment viral miRNAs |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Role of miRNAs in Cancer |
| Record Nr. | UNINA-9910566464803321 |
Navarro Alfons
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Updates on Molecular Targeted Therapies for CNS Tumors
| Updates on Molecular Targeted Therapies for CNS Tumors |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2023 |
| Descrizione fisica | 1 online resource (368 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
A172
A2AAR antagonist adenosine adenosine receptors antigen processing and presentation antioxidant apoptosis ATRX bevacizumab biomarker blood-brain barrier brain metastasis brain tumor cancer metabolism cell cycle arrest central nervous system chemotherapy CNS disease CNS lymphoma CpG island diffuse midline gliomas DNMT EGFR ependymoma EPHB2 epidermal growth factor receptor ERK/MAPK pathway FGFR3 G-CIMP GBM germline mutation glioblastoma glioblastoma molecular classification glioma Group A Group B H3K27M histone acetylation IDH-mutant glioma immune evasion immune score immunotherapy intraparenchymal metastases intrathecal isotope labeling KIF11 leptomeningeal low grade glioma low-grade glioma LPS lung cancer lung carcinoma lung malignancy mass spectrometry meningitis MET metastatic disease Metformin methotrexate methylation methylomics methyltransferases MGMT molecular targets molecular therapy monoclonal antibodies MYCN myxopapillary n/a neoantigen neoplastic neurofibromatosis NF1 novel therapeutics novel therapies patient avatars PCNSL PDGFRA pediatric brain tumor PFA PFB PI3K/PTEN pathway plexiform neurofibroma potential therapy development preclinical models progression progression-free survival radiotherapy receptor tyrosine kinase RELA stereotactic radiosurgery subependymoma T cells T lymphocytes targeted therapy temozolomide tumor microenvironment tumor mutation burden tumor suppressor tyrosine kinase inhibitors U87MG vestibular schwannoma Warburg effect whole-brain radiation therapy YAP1 ZFTA |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9911053032003321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||